BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20663194)

  • 1. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
    Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
    Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.
    Yeo MK; Kim HE; Kim SH; Chae BJ; Song BJ; Lee A
    J Clin Pathol; 2017 Aug; 70(8):715-719. PubMed ID: 28298390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
    Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
    Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer.
    Markiewicz T; Wisniewski P; Osowski S; Patera J; Kozlowski W; Koktysz R
    Anal Quant Cytol Histol; 2009 Feb; 31(1):49-62. PubMed ID: 19320193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
    Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
    Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AutoIHC-scoring: a machine learning framework for automated Allred scoring of molecular expression in ER- and PR-stained breast cancer tissue.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Chakraborty C
    J Microsc; 2017 Nov; 268(2):172-185. PubMed ID: 28613390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer.
    Sundara Rajan S; Horgan K; Speirs V; Hanby AM
    J Clin Pathol; 2014 Jan; 67(1):72-5. PubMed ID: 23986557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.
    Valkonen M; Isola J; Ylinen O; Muhonen V; Saxlin A; Tolonen T; Nykter M; Ruusuvuori P
    IEEE Trans Med Imaging; 2020 Feb; 39(2):534-542. PubMed ID: 31398111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
    Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
    Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
    Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation Index Evaluation in Breast Cancer Using ImageJ and ImmunoRatio Applications.
    Fulawka L; Halon A
    Anticancer Res; 2016 Aug; 36(8):3965-72. PubMed ID: 27466501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.
    Tuominen VJ; Tolonen TT; Isola J
    Histopathology; 2012 Apr; 60(5):758-67. PubMed ID: 22296215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
    Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
    J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.